Reddersen; Gudrun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reddersen; Gudrun.The latest application filed is for "prodrugs of erbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds".

Company Profile

0.8.11

Reddersen; Gudrun - Jena DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy Grant 7,550,451 - Hillisch , et al. June 23, 2	2009-06-23
Estradiol prodrugs Grant 7,534,780 - Wyrwa , et al. May 19, 2	2009-05-19
Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds App 20070197488 - Peters; Olaf ; et al.	2007-08-23
17.alpha.-fluorosteroids, pharmaceutical compositions containing 17.alpha.-fluorosteroids and a method of making them Grant 7,199,115 - Bothe , et al. April 3, 2	2007-04-03
Use of biogenic estrogen sulfamates for hormone replacement therapy Grant 7,053,077 - Elger , et al. May 30, 2	2006-05-30
Estradiol prodrugs App 20050288267 - Wyrwa, Ralf ; et al.	2005-12-29
Steroid prodrugs with androgenic action App 20050282793 - Wyrwa, Ralf ; et al.	2005-12-22
Estriol and estetrol prodrugs App 20050277625 - Wyrwa, Ralf ; et al.	2005-12-15
17alpha-fluorosteroids, pharmaceutical compositions containing 17alpha-fluorosteroids and a method of making them App 20050234027 - Bothe, Ulrich ; et al.	2005-10-20
Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy App 20050026891 - Hillisch, Alexander ; et al.	2005-02-03
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives Grant 6,841,548 - Schwarz , et al. January 11, 2	2005-01-11
Use of biogenic estriol sulfamate prodrugs for treatment of autoimmune diseases App 20040067923 - Elger, Walter ; et al.	2004-04-08
Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy) App 20030130249 - Elger, Walter ; et al.	2003-07-10
C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds Grant 6,583,130 - Schwarz , et al. June 24, 2	2003-06-24
Composition App 20020193444 - Potter, Barry Victor Lloyd ; et al.	2002-12-19
Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives App 20020061868 - Schwarz, Sigfrid ; et al.	2002-05-23
Composition App 20010021707 - Potter, Barry Victor Lloyd ; et al.	2001-09-13
Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds Grant 6,080,735 - Schwarz , et al. June 27, 2	2000-06-27
Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds Grant 5,705,495 - Schwarz , et al. January 6, 1	1998-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.